Acquisition strengthens clinic portfolio for mental health treatment using psychedelic-assisted therapies VANCOUVER, BC, Sept. 23, 2021 /CNW/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced it has closed its acquisition of the Neurology Centre of…


Previous articleMindMed and Liechti Lab Provide Results from their Psilocybin R&D Collaboration
Next articlePTSF78 – Navigating the Vast Psychedelic Space: Where Do You Fit In?